Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease

Plasma S100A12 Levels and Peripheral Arterial Disease in End-Stage Renal Disease

Background: S100A12 is an endogenous ligand of the receptor for advanced glycation end products (RAGE). Plasma S100A12 levels are high in end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis (HD). Peripheral arterial disease (PAD) is common in HD patients and is associated wit...

Full description

Bibliographic Details
Main Authors: Yayoi Shiotsu, Yasukiyo Mori, Tsuguru Hatta, Noboru Maki, Kumiko Iida, Eiko Matsuoka, Hiroshi Kado, Ryo Ishida, Noriko Kishimoto, Keiichi Tamagaki, Masato Nishimura, Noriyuki Iwamoto, Toshihiko Ono, Hiroaki Matsubara, Atsushi Kosaki
Format: Article
Language:English
Published: Karger Publishers 2011-12-01
Series:Nephron Extra
Subjects:
Receptor for advanced glycation end products
S100A12
Peripheral arterial disease
Chronic kidney disease
Online Access:http://www.karger.com/Article/FullText/335198

Internet

http://www.karger.com/Article/FullText/335198

Similar Items